Evaluation of prognostic factors in liver-limited metastatic colorectal cancer: a preplanned analysis of the FIRE-1 trial

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

(2012) H. J. Schmoll et al.   ANNALS OF ONCOLOGY

Evolution of Long-Term Outcome of Liver Resection for Colorectal Metastases: Analysis of Actual 5-Year Survival Rates over Two Decades

(2012) Luca Viganò et al.   ANNALS OF SURGICAL ONCOLOGY

A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer

(2012) M J Proctor et al.   BRITISH JOURNAL OF CANCER

The tumour biology of synchronous and metachronous colorectal liver metastases: a systematic review

(2012) A. A. P. Slesser et al.   CLINICAL & EXPERIMENTAL METASTASIS

Prognostic factors in patients with non resectable metastatic colorectal cancer in the era of targeted biotherapies: Relevance of Köhne's risk classification

(2012) Elise Desot et al.   DIGESTIVE AND LIVER DISEASE

Resectability and outcome with anti-EGFR agents in patients with KRAS wild-type colorectal liver-limited metastases: a meta-analysis

(2012) F. Petrelli et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Effectiveness of Liver Metastasectomies in Patients With Metastatic Colorectal Cancer Treated With FIr-B/FOx Triplet Chemotherapy Plus Bevacizumab

(2011) Gemma Bruera et al.   Clinical Colorectal Cancer

Simplified Prognostic Model in Patients with Oxaliplatin-Based or Irinotecan-Based First-Line Chemotherapy for Metastatic Colorectal Cancer: A GERCOR Study

(2011) B. Chibaudel et al.   ONCOLOGIST

Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer--an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009

(2010) R. Adam et al.   ANNALS OF ONCOLOGY

Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases

(2010) L J M Mekenkamp et al.   BRITISH JOURNAL OF CANCER

Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma

(2010) Thomas K. Eigentler et al.   CANCER

Chemotherapy for the conversion of unresectable colorectal cancer liver metastases to resection

(2010) Derek G. Power et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Elevated LDH predicts poor outcome of recurrent germ cell tumours treated with dose dense chemotherapy

(2010) Marco Gerlinger et al.   EUROPEAN JOURNAL OF CANCER

Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer

(2010) Ludwig Fischer von Weikersthal et al.   EUROPEAN JOURNAL OF CANCER

Evaluation of Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer

(2009) Myrddin Rees et al.   ANNALS OF SURGERY

Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy

(2009) Scott Kopetz et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

(2009) Gunnar Folprecht et al.   LANCET ONCOLOGY

Five-Year Data and Prognostic Factor Analysis of Oxaliplatin and Irinotecan Combinations for Advanced Colorectal Cancer: N9741

(2008) Hanna K. Sanoff et al.   JOURNAL OF CLINICAL ONCOLOGY